Skip to main content
. 2015 Dec 30;10(4):449–454. doi: 10.1093/ecco-jcc/jjv235

Table 4.

Prediction of clinical remission by smoking habits at baseline.

Remission
Yes No
n % n %
Study Treatment Smoking status 5 20.8 3 50.0
BUC-60 Budesonide Current smoker
Former smoker 5 20.8 2 33.3
Never smoked 14 58.3 1 16.7
Total 24 100.0 6 100.0
Mesalazine Smoking status 3 37.5 8 47.1
Current smoker
Former smoker 1 12.5 3 17.6
Never smoked 4 50.0 6 35.3
Total 8 100.0 17 100.0
Placebo Smoking status 2 14.3 10 43.5
Current smoker
Former smoker 3 21.4 7 30.4
Never smoked 9 64.3 6 26.1
Total 14 100.0 23 100.0
BUC-63 Budesonide Smoking status 37 39.8 4 28.6
Current smoker
Former smoker 29 31.2 8 57.1
Never smoked 27 29.0 2 14.3
Total 93 100.0 14 100.0

Current + former smokers vs non-smokers in the placebo group: odds ratio (OR) 0.21, 95% confidence interval (CI) 0.04–1.00, p = 0.04.

Current smokers vs non-smokers in the placebo group: OR 0.14, 95% CI 0.01–1.04, p = 0.05.